Hong Kong Blood Typing, Grouping and Infectious Disease NAT Screening Market 2020-2024 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "2024 Hong Kong Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier…
6 years ago
Wire Stories
WELLE Group Announces 2019 Annual Results
CHANGZHOU, China--(BUSINESS WIRE)--WELLE Group has announced its annual results for 2019. Highlights are in the…
6 years ago
Opportunities and Risks in the Cards & Payments Market in Japan 2020-2023: The Outbreak of COVID-19 is Driving Non-Cash Payments – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Japan Cards & Payments: Opportunities and Risks to 2023" report has been added…
6 years ago
WorldRemit Launches the Inaugural List of Influential Filipinos in the Diaspora
In celebration of Philippines Independence Day, the list recognises the contributions of Filipinos across the…
6 years ago
Amphenol Presented “2019 Best Asia Performance Award” to Heilind Asia Pacific
HONG KONG--(BUSINESS WIRE)--Heilind Asia Pacific, part of Heilind Electronics Inc., was awarded the “2019 Best…
6 years ago
Burden of COVID-19 on the Market & Rehabilitation Plan | N95 Respirators Market In APAC 2020-2024 | The Rising Prevalence Of Pandemic Diseases to Boost Growth | Technavio
LONDON--(BUSINESS WIRE)--#N95RespiratorsMarketinAPAC--Technavio has been monitoring the N95 respirators market in APAC and it is poised…
6 years ago
PFG Partners With Sydney-based Customer Communication Platform Vero
SYDNEY--(BUSINESS WIRE)--Vero, a marketing automation software business recently closed a funding round from Partners for…
6 years ago
WorldRemit Partners with Vodafone Fiji M-PAISA Mobile Money to Offer Zero Fee Money Transfers
WorldRemit and Vodafone Fiji M-PAISA have waived remittance fees for senders in five countries, enabling…
6 years ago
Piedmont Lithium Limited Announces Closing of Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
NEW YORK--(BUSINESS WIRE)--$PLL #Lithium--Piedmont Lithium Limited, (Nasdaq, ASX: PLL), today announced the closing of its…
6 years ago
Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients
Centanafadine, an investigational compound for the treatment of ADHD, demonstrated statistically significant improvements vs. placebo…
6 years ago